Survival Prognosis
Survival prognosis refers to the predicted outcome of a disease, typically measured by the probability of survival over a specific period. It is influenced by tumor biology, treatment response, and individual patient factors.
Key Determinants
- Tumor Stage and Grade: Extent of spread and cellular differentiation.
- Treatment Modality: Efficacy of surgery, chemotherapy, radiation, or emerging therapies.
- Patient Physiology: Age, comorbidities, and immune status.
Emerging Therapeutic Interventions
Recent case studies highlight non-traditional approaches that may alter standard prognostic models:
- Oncolytic Virotherapy: Use of genetically modified viruses to selectively infect and kill cancer cells while sparing normal tissue.
- Self-Administration Protocols: Cases such as Self-Administered Oncolytic Virotherapy in Recurrent Breast Cancer: Dr. Halassy’s Case demonstrate potential for patient-led management of recurrent breast cancer.
- Case Context: Dr. Beata Halassy, a Croatian virologist, utilized self-administered oncolytic virotherapy after multiple recurrences despite conventional surgery and chemotherapy.
- Prognostic Implication: Suggests that refractory cases may benefit from targeted viral therapies when standard options are exhausted.
References
- Kurzgesagt – In a Nutshell. Self-Administered Oncolytic Virotherapy in Recurrent Breast Cancer: Dr. Halassy’s Case.